<DOC>
	<DOCNO>NCT02006290</DOCNO>
	<brief_summary>The B7441003 study assess PF-06412562 motor benefit Parkinson 's disease subject . Safety , tolerability PK PF-06412562 Parkinson 's disease subject also evaluate .</brief_summary>
	<brief_title>Efficacy , Safety And Tolerability Study In Subjects With Parkinson 's Disease</brief_title>
	<detailed_description />
	<mesh_term>Parkinson Disease</mesh_term>
	<criteria>Male female subject diagnosis idiopathic Parkinson 's disease . Daily Ldopa dose 300 1200 mg. MBRS score &gt; 1 . Surgical intervention Parkinson 's disease . History troublesome dyskinesia . Any significant AXIS I psychiatric disease .</criteria>
	<gender>All</gender>
	<minimum_age>30 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>September 2015</verification_date>
</DOC>